Table 4.
Comparison of the changes in concentrations of each variable for the cinnamon supplementation and placebo T2DM groups at the end of the study
| Conc. change for cinnamon supplement (n = 49) | Conc. change for placebo group (n = 50) | p value* | |
|---|---|---|---|
| Systolic BP (mmHg) | 8.5 (5.0 to 13.3) | −5.0 (−13.3 to 3.0) | <0.001 |
| Diastolic BP (mmHg) | 8.0 (5.0 to 12.0) | −0.5 (−14.0 to 5.3) | 0.002 |
| Glucose (mmol/l) | 0.55 (0.47 to 1.82) | −0.50 (−1.60 to 0.52) | 0.001 |
| BUN (mmol/l) | 1.07 (0.53 to 2.14) | −0.71 (−2.14 to 1.25) | 0.006 |
| CT(µmol/l) | 8.84 (8.84 to 0.40) | −8.84 (−26.52 to 8.84) | <0.001 |
| eGFR (ml/min/1.73 m2) | −6.85 (−25.98 to 9.36) | 3.47 (2.02 to 9.52) | <0.001 |
| Total cholesterol (mmol/l) | −0.15 (−0.89 to 0.31) | −0.28 (−0.68 to 0.26) | <0.001 |
| Triglyceride (mmol/l) | 0.32 (−0.05 to 0.95) | −0.011 (−0.50 to 0.25) | <0.001 |
| HDL-C (mmol/l) | −0.26 (−0.36 to −0.12) | 0.026 (−0.285 to 0.207) | <0.001 |
| LDL-C (mmol/l) | −0.18 (−0.69 to 0.34) | 0.05 (−0.44 to 0.40) | 0.178 |
| TG/HDL-C ratio | 0.95 (0.18 to 2.02) | 0.14 (−0.62 to 1.21) | <0.001 |
| HbA1c (mmol/mol) | 0.9 (0.0 to 1.3) | −0.14 (−0.62 to 1.21) | <0.001 |
* Mann–Whitney U test